23.5JPY
3.04 BJPY
28.71 BJPY
95.61 M
About PEPTIDREAM INC
Sector
Industry
CEO
Patrick Crawford Reid
Website
Headquarters
Kawasaki
Employees (FY)
603
Founded
2006
ISIN
JP3836750004
FIGI
BBG004JMYDH8
PeptiDream, Inc. engages in the biopharmaceutical business that includes research and development of non-standard peptide therapeutics. It produces macrocyclic peptides based on its proprietary Peptide Discovery Platform System (PDPS). The company was founded by Kiichi Kubota and Hiroaki Suga on July 3, 2006 and is headquartered in Kawasaki, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4587 is 1468.5 JPY — it has decreased by 3.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange PEPTIDREAM INC stocks are traded under the ticker 4587.
PEPTIDREAM INC is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
4587 stock is 6.11% volatile and has beta coefficient of 1.49. Check out the list of the most volatile stocks — is PEPTIDREAM INC there?
One year price forecast for PEPTIDREAM INC has a max estimate of 4900.0 JPY and a min estimate of 1400.0 JPY.
4587 earnings for the last quarter are 32.92 JPY whereas the estimation was 28.19 JPY which accounts for 16.77% surprise. Estimated earnings for the next quarter are 2.51 JPY. See more details about PEPTIDREAM INC earnings.
PEPTIDREAM INC revenue for the last quarter amounts to 13.12 B JPY despite the estimated figure of 11.05 B JPY. In the next quarter revenue is expected to reach 7.46 B JPY.
Yes, you can track PEPTIDREAM INC financials in yearly and quarterly reports right on TradingView.
4587 stock has fallen by 3.64% compared to the previous week, the month change is a 8.38% rise, over the last year PEPTIDREAM INC has showed a 22.05% decrease.
4587 net income for the last quarter is −505.60 M JPY, while the quarter before that showed 4.27 B JPY of net income which accounts for −111.84% change. Track more PEPTIDREAM INC financial stats to get the full picture.
Today PEPTIDREAM INC has the market capitalization of 196.81 B, it has increased by 2.53% over the last week.
No, 4587 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4587 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PEPTIDREAM INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 603.00 employees. See our rating of the largest employees — is PEPTIDREAM INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PEPTIDREAM INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PEPTIDREAM INC stock shows the sell signal. See more of PEPTIDREAM INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PEPTIDREAM INC future price: according to them, 4587 price has a max estimate of 4900.00 JPY and a min estimate of 1400.00 JPY. Read a more detailed PEPTIDREAM INC forecast: see what analysts think of PEPTIDREAM INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PEPTIDREAM INC EBITDA is 9.24 B JPY, and current EBITDA margin is 33.46%. See more stats in PEPTIDREAM INC financial statements.